The WHO recommends integrase strand transfer inhibitors (INSTIs) as first-line treatment for HIV, but there's limited data on drug resistance in resource-limited settings like Cameroon.
In a study of 56 INSTI-naive patient viral sequences from Cameroon, researchers analyzed 37 high-quality sequences, finding the majority belonged to the CRF02_AG subtype.
The analysis revealed that 18.9% of the sequences had resistance-associated mutations (RAMs), with only 5.4% showing major RAMs that could affect treatment, highlighting the need for further monitoring in resource-limited areas.